The success of copyright’s blockbuster initially drove a surge for major pharmaceutical companies, but recent developments present a uncertain picture for those considering a stake. Lower-cost versions are eroding https://rafaelbzba507505.blogs100.com/41580484/the-blue-pill-and-big-pharma-a-risky-bet